Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Biomind Labs Inc. Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications September 14, 2023 From Biomind Labs Inc. Via Business Wire Tickers BMNDF Biomind Labs Doses First Subject in Phase I/IIa Clinical Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression April 26, 2022 From Biomind Labs Inc. Via Business Wire Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form November 18, 2021 From Biomind Labs Inc. Via Business Wire Biomind Labs to Advance a Phase II Clinical Trial on DMT for Treatment-Resistant Depression August 18, 2021 From Biomind Labs Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.